Dr. Clarissa Koch, PhD

Chief Scientific Officer at Leyden Labs

Speaker

As CSO at Leyden Labs, I lead scientific strategy and research efforts behind antibody-based nasal sprays designed to prevent infection from influenza, coronaviruses, and other respiratory viruses. This work is centered on building scalable, non-invasive prophylactic platforms that enable broad protection against current and emerging respiratory viral threats. I began my academic training at Smith College, and received a B.Sc. in Biomedical Sciences at the University of Amsterdam. I completed my Ph.D. at Boston University, followed by postdoctoral training in the Division of Pulmonary and Critical Care at Northwestern University, where my research focused on respiratory viral pathogens including influenza, RSV, and SARS-CoV-2. Prior to joining Leyden Labs, I worked on precision oncology approaches for breast cancer at Agendia.